Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PFIZER INC : RBC sticks Neutral

07/29/2021 | 07:49am EDT

RBC confirms his opinion on the stock and remains Neutral. The target price remains unchanged at USD 44.


ę MarketScreener with dpa-AFX Analyser 2021
All news about PFIZER, INC.
04:00aPFIZER : Thai campaign to vaccinate schoolchildren makes progress
AQ
03:12aMARKETMIND : Losing the plot
RE
09/20PFIZER : vaccine found to be safe, effective for children aged 5-11
AQ
09/20PFIZER : announces its vaccine is effective for kids 5-11
AQ
09/20Healthcare Shares Fall Amid Concerns About Delta Variant -- Healthcare Roundu..
DJ
09/20Chevron, D.R. Horton fall; Pfizer, Brooks Automation rise
AQ
09/20MODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
RE
09/20MODERNA : Regulators could OK Pfizer boosters for older Americans this week
RE
09/20ASTELLAS PHARMA : ' and pfizer's xtandi (enzalutamide) reduced risk of death by ..
AQ
09/20PFIZER : BioNTech Study Shows COVID-19 Vaccine Generates Strong Immune Response ..
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 80 761 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,1x
Yield 2021 3,57%
Capitalization 248 B 248 B -
EV / Sales 2021 3,43x
EV / Sales 2022 4,05x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 44,20 $
Average target price 45,02 $
Spread / Average Target 1,86%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.19.23%247 816
JOHNSON & JOHNSON4.09%433 701
ROCHE HOLDING AG10.97%321 442
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY37.20%208 604
ABBVIE INC.-0.70%190 378